0001181431-12-064438.txt : 20121213 0001181431-12-064438.hdr.sgml : 20121213 20121213153043 ACCESSION NUMBER: 0001181431-12-064438 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121212 FILED AS OF DATE: 20121213 DATE AS OF CHANGE: 20121213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin Tami Tillotson CENTRAL INDEX KEY: 0001539494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 121262044 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 1550 EAST GUDE DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 rrd363472.xml X0306 4 2012-12-12 0 0001356576 SUPERNUS PHARMACEUTICALS INC SUPN 0001539494 Martin Tami Tillotson C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850 0 1 0 0 VP of Regulatory Affairs Common Stock 2012-12-12 4 M 0 37500 1.6 A 40000 D Common Stock 2012-12-12 4 M 0 1250 3.36 A 41250 D Common Stock 2012-12-12 4 M 0 9375 2.56 A 50625 D Employee Stock Option (right to buy) 1.60 2012-12-12 4 M 0 37500 0 D 2018-07-16 Common Stock 37500 0 D Employee Stock Option (right to buy) 3.36 2012-12-12 4 M 0 1250 0 D 2020-02-10 Common Stock 1250 1250 D Employee Stock Option (right to buy) 2.56 2012-12-12 4 M 0 9375 0 D 2020-11-02 Common Stock 9375 28125 D 25% of the shares subject to the option vested on each of 7/16/2009, 7/16/2010, 7/16/2011 and 7/16/2012. 25% of the shares subject to the option vested on each of 2/10/2011 and 2/10/2012, and the remaining shares subject to the option will vest in approximately equal installments on 2/10/13 and 2/10/14. 25% of the shares subject to the option vested on 11/2/2011, and the remaining shares subject to the option will vest in approximately equal quarterly installments over the following three years. /s/ Gregory S. Patrick, as attorney-in-fact 2012-12-13